Is breast cancer overdiagnosis also nested in pathologic misclassification?

Radiology

Volumn 273, Issue 3, 2014, Pages 652-655

  Colin, Catherine ^a   Devouassoux Shisheboran, Mojgan ^b   Sardanelli, Francesco ^c,d  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c UNIVERSITY OF MILAN   (Italy)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ATYPICAL DUCTAL HYPERPLASIA; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER OVERDIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SCREENING; CHROMOSOME DELETION; CLINICAL PRACTICE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DUCTAL INTRAEPITHELIAL NEOPLASIA; HISTOPATHOLOGY; HUMAN; IMAGE ENHANCEMENT; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MEDICAL ERROR; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERTREATMENT; PARTIAL MASTECTOMY; PATHOLOGIC MISCLASSIFICATION; PRECANCER AND CANCER-IN-SITU; PREOPERATIVE EVALUATION; RECURRENCE RISK; REFERENCE VALUE; REPRODUCIBILITY; REVIEW; RISK REDUCTION; TUMOR GROWTH; TUMOR INVASION; TUMOR VOLUME; BIOPSY; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FEMALE; PATHOLOGY; PREVENTION AND CONTROL;

BIOPSY; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DIAGNOSTIC IMAGING; EARLY DETECTION OF CANCER; FEMALE; HUMANS;

EID: 84916626662     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14141116     Document Type: Review

References (37)

1. Virnig BA, Wang SY, Shamilyan T, Kane RL, Tuttle TM. Ductal carcinoma in situ: Risk factors and impact of screening. J Natl Cancer Inst Monogr 2010;2010(41):113-116
2. Lynge E, Ponti A, James T, et al. Variation in detection of ductal carcinoma in situ during screening mammography: A survey within the International Cancer Screening Network. Eur J Cancer 2014;50(1):185-192
3. Kennedy F, Harcourt D, Rumsey N. Perceptions of ductal carcinoma in situ (DCIS) among UK health professionals. Breast 2009;18(2):89-93
4. Rakovitch E, Franssen E, Kim J, et al. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 2003;77(3):285-293
5. De Morgan S, Redman S, White KJ, Cakir B, Boyages J. "Well, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ. Health Expect 2002;5(4):310-318
6. Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: How much more breast cancer can we find? Ann Intern Med 1997;127(11):1023-1028
7. Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: A review. Breast Cancer Res Treat 2006;97(2):135-144
8. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-aged women: A study of 110 medicolegal autopsies. Br J Cancer 1987;56(6):814-819
9. Wells WA, Carney PA, Eliassen MS, Tosteson AN, Greenberg ER. Statewide study of diagnostic agreement in breast pathology. J Natl Cancer Inst 1998;90(2):142-145
10. Collins LC, Connolly JL, Page DL, et al. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: Results from a randomized clinical trial. Am J Surg Pathol 2004;28(1):126-131
11. Costarelli L, Campagna D, Mauri M, Fortunato L. Intraductal proliferative lesions of the breast-terminology and biology matter: Premalignant lesions or preinvasive cancer? Int J Surg Oncol 2012;2012:501904
12. Calhoun BC, Livasy CA. Mitigating overdiagnosis and overtreatment in breast cancer: what is the role of the pathologist? Arch Pathol Lab Med 2014 Feb 27. [Epub ahead of print]
13. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, Van de Vijver MJ, eds. WHO classification of tumours of the breast. 4th ed. Lyon, France: IARC, 2012
14. Jain RK, Mehta R, Dimitrov R, et al. Atypical ductal hyperplasia: Interobserver and intraobserver variability. Mod Pathol 2011;24(7):917-923
15. Elston CW, Sloane JP, Amendoeira I, et al. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology. Eur J Cancer 2000;36(14):1769-1772
16. Sloane JP, Amendoeira I, Apostolikas N, et al. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol 1998;29(10):1056-1062
17. Ghofrani M, Tapia B, Tavassoli FA. Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: Results of a multinational survey. Virchows Arch 2006;449(6):609-616
18. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991;15(3):209-221
19. Douglas-Jones AG, Gupta SK, Attanoos RL, Morgan JM, Mansel RE. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): Correlation with grade of associated invasive carcinoma. Histopathology 1996;29(5):397-409
20. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 1992;23(10):1095-1097
21. Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990;65(3):518-529
22. Tavassoli FA. Ductal carcinoma in situ: Introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 1998;11(2):140-154
23. de Mascarel I, Brouste V, Asad-Syed M, Hurtevent G, Macgrogan G. All atypia diagnosed at stereotactic vacuum-assisted breast biopsy do not need surgical excision. Mod Pathol 2011;24(9):1198-1206
24. Piubello Q, Parisi A, Eccher A, Barbazeni G, Franchini Z, Iannucci A. Flat epithelial atypia on core needle biopsy: which is the right management? Am J Surg Pathol 2009;33(7):1078-1084
25. Uzoaru I, Morgan BR, Liu ZG, et al. Flat epithelial atypia with and without atypical ductal hyperplasia: To re-excise or not-results of a 5-year prospective study. Virchows Arch 2012;461(4):419-423
26. Ely KA, Carter BA, Jensen RA, Simpson JF, Page DL. Core biopsy of the breast with atypical ductal hyperplasia: A probabilistic approach to reporting. Am J Surg Pathol 2001;25(8):1017-1021
27. Forgeard C, Benchaib M, Guerin N, et al. Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? a retrospective study of 300 patients. Am J Surg 2008;196(3):339-345
28. Shatat L, Gloyeske N, Madan R, O'Neil M, Tawfik O, Fan F. Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics. Hum Pathol 2013;44(12):2684-2689
29. Prasad ML, Osborne MP, Giri DD, Hoda SA. Microinvasive carcinoma (T1mic) of the breast: Clinicopathologic profile of 21 cases. Am J Surg Pathol 2000;24(3):422-428
30. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR. Molecular evolution of breast cancer. J Pathol 2005;205(2):248-254
31. Wiechmann L, Kuerer HM. The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 2008;112(10): 2130-2142
32. Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 2008;32(4):513-523
33. Boughey JC, Gonzalez RJ, Bonner E, Kuerer HM. Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist 2007;12(11):1276-1287
34. Houssami N, Turner R, Macaskill P, et al. An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol 2014;32(5):392-401
35. Londero V, Zuiani C, Linda A, Girometti R, Bazzocchi M, Sardanelli F. High-risk breast lesions at imaging-guided needle biopsy: Usefulness of MRI for treatment decision. AJR Am J Roentgenol 2012;199(2):W240-W250
36. Hahn SY, Han BK, Ko EY, Shin JH, Hwang JY, Nam M. MR features to suggest microinvasive ductal carcinoma of the breast: Can it be differentiated from pure DCIS? Acta Radiol 2013;54(7):742-748
37. Emperor Justinian. Institutiones.http://www.treccani.it/vocabolario/nomina-suntconsequentia-rerum/. Accessed May 4, 2014.